← Leaderboards
Matthew J Sikora
University Of Pittsburgh At Pittsburgh
$3,621,914
Attributed
$4,525,509
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,525,509 · 5
By mechanism
R01$3,560,824 · 2
R00$703,379 · 1
K99$256,306 · 1
R13$5,000 · 1
Top collaborators
- Benjamin G Bitler3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- George C. Tseng$5,515,023
- Kevin Max Levine$170,265
- Jie Bin Liu$161,206
- Laura P. Stabile$550,289
- Emily Ann Bossart$83,644
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSignal TransductionResistanceTherapy ResistantMediatingGrowthSmall Interfering RnaRegulationMalignant Epithelial CellAffectWomanKnock-DownPatient-Focused OutcomesCancer SubtypesSignal PathwayHormone TherapyMalignant Breast NeoplasmResponseEndocrinePatient CareGenesFoundationsComplexFunctional Disorder
Grant awards (13)
MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma$711,413
R01 · FY2025 · CA · contact PI
Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities$595,487
R01 · FY2025 · CA · contact PI
Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities$566,139
R01 · FY2024 · CA · contact PI
MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma$337,922
R01 · FY2024 · CA · contact PI
Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities$645,565
R01 · FY2023 · CA · contact PI
MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma$348,592
R01 · FY2023 · CA · contact PI
MDC1: central regulator of estrogen receptor function and therapy response in lobular carcinoma$355,706
R01 · FY2022 · CA · contact PI
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA$236,030
R00 · FY2019 · CA · contact PI
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA$218,349
R00 · FY2018 · CA · contact PI
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA$249,000
R00 · FY2017 · CA · contact PI
Elucidating the function of WNT4 in endocrine response and resistance in invasive lobular carcinoma$128,153
K99 · FY2016 · CA · contact PI
Elucidating the function of WNT4 in endocrine response and resistance in invasive lobular carcinoma$128,153
K99 · FY2015 · CA · contact PI
2015 Hormone-Dependent Cancers Gordon Research Conference and Gordon Research Seminar$5,000
R13 · FY2015 · CA · contact PI